This CME-certified webinar will feature a review and discussion of patient case studies and key clinical trial data with renowned clinical experts providing their perspectives on recent advances with BTK inhibitors in the treatment of chronic lymphocytic leukemia (CLL). Along with the presenting faculty, attendees will be challenged to manage clinically relevant cases and will have multiple opportunities to directly interact with faculty in a dynamic question and answer format. Critical insights on the similarities and differences among multiple different BTK inhibitors will help prepare attendees to safely and effectively use these agents in their practice. In addition, the faculty will integrate results from CCO’s exclusive Interactive Decision Support Tools for CLL and BTK inhibitor adverse event management for all case discussions. Thousands of cases have been entered into these online decision tools to date, and data from this resource will be used to focus the content and cases discussed.